Dr Reddys Laboratories Income Statement (2009-2026)

Reported Financials

Dr Reddys Laboratories Quarterly Income Statement

Periods 70 quarters

Latest Jun 2026

Dr Reddys Laboratories reported revenue of $0.85B and net income of $0.05B for the quarter ended Jun 2026, down 14.6% year over year. This income statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue	0.70B	0.72B	0.72B	0.68B	0.82B	0.77B	0.81B	0.83B	0.83B	0.87B	0.85B	0.92B	0.96B	0.99B	0.98B	1.00B	1.01B	0.98B	0.82B	0.85B
Cost of RevenueCost of Rev	0.32B	0.34B	0.34B	0.34B	0.34B	0.33B	0.34B	0.34B	0.34B	0.36B	0.35B	0.36B	0.39B	0.41B	0.44B	0.43B	0.46B	0.45B	0.45B	0.46B
Gross Profit	0.38B	0.38B	0.38B	0.34B	0.49B	0.44B	0.48B	0.49B	0.49B	0.51B	0.50B	0.56B	0.57B	0.58B	0.55B	0.57B	0.55B	0.53B	0.37B	0.40B
Operating items
Amortization - Intangibles
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D	0.06B	0.06B	0.06B	0.06B	0.06B	0.07B	0.06B	0.07B	0.07B	0.07B	0.08B	0.07B	0.09B	0.08B	0.08B	0.07B	0.07B	0.07B	0.06B	0.06B
Selling, General & AdministrativeSG&A	0.20B	0.21B	0.21B	0.20B	0.22B	0.22B	0.21B	0.23B	0.23B	0.24B	0.25B	0.27B	0.27B	0.29B	0.28B	0.30B	0.01B	0.30B	0.30B	0.30B
Other Operating ExpensesOther Opex	-0.01B	-0.01B	0.10B	-0.08B	0.01B	-0.00B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	70.15B	-0.01B	0.27B	74.44B	77.90B	-0.01B
Operating ExpensesOpex	0.25B	0.26B	0.36B	0.18B	0.26B	0.29B	0.29B	0.27B	0.27B	0.30B	0.32B	0.34B	0.36B	0.36B	70.51B	0.36B	0.35B	74.81B	78.27B	0.36B
Operating IncomeOp. Inc	0.12B	0.07B	0.02B	0.16B	0.20B	0.15B	0.21B	0.21B	0.22B	0.21B	0.18B	0.21B	0.21B	0.22B	0.20B	0.20B	0.20B	0.16B	0.01B	0.04B
EBIT	0.12B	0.07B	0.02B	0.16B	0.20B	0.15B	0.21B	0.21B	0.22B	0.21B	0.18B	0.21B	0.21B	0.22B	0.20B	0.20B	0.20B	0.16B	0.01B	0.04B
Non-operating items
Non Operating Interest Expenses	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	0.66B	-0.01B	-0.01B	0.94B	1.06B	-0.01B
Interest & Investment IncomeInt & Inv Inc	-0.00B	-0.01B	0.02B	0.03B	0.00B	0.00B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.03B	0.01B	0.03B	0.03B	0.02B	0.02B	0.02B	0.03B
Other Non Operating IncomeOther Non Op Inc.	-0.02B	-0.00B	0.01B	-0.08B	-0.00B	0.01B	-0.00B	-0.01B	-0.02B	0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.03B	-0.01B	-0.03B	-0.01B	-0.04B	-0.01B
Non Operating IncomeNon Op. Inc.										-0.01B	-0.01B		-0.01B	-0.01B
Net income details
EBT	0.13B	0.08B	0.03B	0.19B	0.20B	0.16B	0.22B	0.23B	0.23B	0.22B	0.19B	0.23B	0.23B	0.22B	0.23B	0.22B	0.21B	0.17B	0.02B	0.06B
Tax ProvisionsTaxes	0.04B	0.03B	0.02B	0.04B	0.05B	0.04B	0.05B	0.06B	0.05B	0.05B	0.04B	0.06B	0.07B	0.06B	0.05B	0.06B	0.05B	2.07B	-0.24B	0.01B
Profit After TaxPAT	0.09B	0.05B	0.02B	0.15B	0.15B	0.12B	0.17B	0.18B	0.18B	0.21B	0.18B	0.17B	0.21B	0.22B	90.50B	0.16B	0.20B	90.22B	80.22B	0.05B
Equity Income	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B
Income from Non-Controlling InterestsInc. Minority													0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B
Income from Continuing OperationsIncome (Continuing)	0.09B	0.05B	0.01B	0.15B	0.15B	0.12B	0.17B	0.17B	0.18B	0.17B	0.16B	0.17B	0.16B	0.17B	0.18B	0.16B	0.16B	-1.90B	0.26B	0.05B
Consolidated Net IncomeConsol Net Inc.	0.09B	0.05B	0.01B	0.15B	0.15B	0.12B	0.17B	0.17B	0.18B	0.17B	0.16B	0.17B	0.16B	0.17B	0.18B	0.16B	0.16B	-1.90B	0.26B	0.05B
Income towards Parent CompanyParent Net Inc	0.09B	0.05B	0.01B	0.15B	0.15B	0.12B	0.17B	0.17B	0.18B	0.17B	0.16B	0.17B	0.15B	0.17B	-0.07B	0.17B	0.16B	-0.20B	0.00B	0.05B
Net Income towards Common StockholdersNet Income	0.09B	0.05B	0.01B	0.15B	0.15B	0.12B	0.17B	0.17B	0.18B	0.17B	0.16B	0.17B	0.15B	0.17B	-0.07B	0.17B	0.16B	-0.20B	0.00B	0.05B
Additional items
EPS (Basic)	0.11	0.06	0.01	0.19	0.18	0.14	0.20	0.20	0.22	0.20	0.19	0.20	0.18	0.20	-0.08	0.20	0.20	-0.24	0.00	0.06
EPS (Diluted)	0.11	0.06	0.01	0.19	0.18	0.14	0.20	0.20	0.22	0.20	0.19	0.20	0.18	0.20	-0.08	0.20	0.20	-0.24	0.00	0.06
Shares Outstanding	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B	0.83B
Shares Outstanding (Entity)Shares Outstanding (Entity.)			0.83B				0.83B				0.83B				0.83B				0.83B
EBITDA	0.12B	0.07B	0.02B	0.16B	0.20B	0.15B	0.21B	0.21B	0.22B	0.21B	0.18B	0.21B	0.21B	0.22B	0.20B	0.20B	0.20B	0.16B	0.01B	0.04B
Interest ExpensesInt Expense	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	0.66B	-0.01B	-0.01B	0.94B	1.06B	-0.01B
Tax Rate	27.34%	40.74%	64.76%	18.96%	23.62%	27.78%	23.87%	26.09%	22.65%	24.47%	18.39%	26.04%	30.01%	25.10%	20.85%	25.99%	22.25%	1,197.05%	-1,088.16%	21.32%

Dr Reddys Laboratories RDY Income Statement (2009-2026)

Dr Reddys Laboratories Quarterly Income Statement

Create an account

Sign In

Reset Password